About Ospedale Fabrizio Spaziani
Clinical Trials at Ospedale Fabrizio Spaziani
During the past decade, Ospedale Fabrizio Spaziani conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ospedale Fabrizio Spaziani" #1 sponsor was "Consorzio Oncotech" with 3 trials, followed by "Biotronik SE & Co. KG" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored and "National Cancer Institute, Naples"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Fabrizio Spaziani"
#1 collaborator was "Clinical Research Technology S.r.l." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Ospedale Fabrizio Spaziani
According to Clinical.Site data, the most researched conditions in "Ospedale Fabrizio Spaziani" are
"Metastatic Breast Cancer" (3 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Human Epidermal Growth Factor 2 Negative Carcinoma of Breast" (1 trials) and "Non-small Cell Lung Cancer Metastatic" (1 trials). Many other conditions were trialed in "Ospedale Fabrizio Spaziani" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Fabrizio Spaziani
Most popular intervention types in "Ospedale Fabrizio Spaziani" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (1 trials), "Bevacizumab and eribulin" (1 trials), "Cisplatin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials) and "DDD(R)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Fabrizio Spaziani
The vast majority of trials in "Ospedale Fabrizio Spaziani" are
5 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Ospedale Fabrizio Spaziani
Currently, there are NaN active trials in "Ospedale Fabrizio Spaziani".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ospedale Fabrizio Spaziani,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Fabrizio Spaziani, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".